Quantitative evaluation of MR perfusion imaging using blood pool contrast agent in subjects without pulmonary diseases and in patients with pulmonary embolism.
To assess the feasibility of time-resolved parallel three-dimensional magnetic resonance imaging (MRI) for quantitative analysis of pulmonary perfusion using a blood pool contrast agent. Quantitative perfusion analysis was performed using novel software to assess pulmonary blood flow (PBF), pulmonary blood volume (PBV) and mean transit time (MTT) in a quantitative manner. The evaluation of lung perfusion in the normal subjects showed an increase of PBF, PBV ventrally to dorsally (gravitational direction), and the highest values at the upper lobe, with a decrease to the middle and lower lobe (isogravitational direction). MTT showed no relevant changes in either the gravitational or isogravitational directions. In comparison with normally perfused lung areas (in diseased patients), the pulmonary embolism (PE) regions showed a significantly lower mean PBF (20 ± 0.6 ml/100 ml/min, normal region 94 ± 1 ml/100 ml/min; P < 0.001), mean PBV (2 ± 0.1 ml/100 ml, normal region 9.8 ± 0.1 ml/100 ml; P < 0.001) and mean MTT (3.8 ± 0.1 s; normal region 6.3 ± 0.1; P < 0.001). Our results demonstrate the feasibility of using time-resolved dynamic contrast-enhanced MRI to determine normal range and regional variation of pulmonary perfusion and perfusion deficits in patients with PE. • Recently introduced blood pool contrast agents improve MR evaluation of lung perfusion • Regional differences in lung perfusion indicating a gravitational and isogravitational dependency. • Focal areas of significantly decreased perfusion are detectable in pulmonary embolism.